<https://rdf.molmedb.upol.cz/reference/ref4168> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494353>,
		<https://rdf.molmedb.upol.cz/interaction/membrane19>,
		<https://identifiers.org/molmedb/MM494356>,
		<https://identifiers.org/molmedb/MM00482>;
	<http://purl.org/dc/terms/bibliographicCitation> "Tripathi PN, Srivastava P, Sharma P, Seth A, Shrivastava SK.: Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions. Bioorg Med Chem, Volume 27 (7), 2019"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmc.2019.02.031"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494347>,
		<https://rdf.molmedb.upol.cz/interaction/method30>;
	<http://purl.org/ontology/bibo/pmid> "30795991"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1018643> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4168> .
<https://rdf.molmedb.upol.cz/interaction/int1018652> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4168> .
<https://rdf.molmedb.upol.cz/interaction/int1019084> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4168> .
<https://rdf.molmedb.upol.cz/interaction/int1018649> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4168> .